UCL Medical Sciences has formed a strategic research collaboration with Servier. Together, we are advancing the discovery of therapies for lupus and systemic sclerosis.
Our new partnership enables UCL to develop and distribute an imaging agent, furthering the understanding and treatment of neurodegenerative disease.
Our immune response becomes less effective as we grow older. Thanks to this collaboration, we now understand how the body reacts, paving the way for new treatments for disease.